echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > The latest appointment for Pfizer's oncology business

    The latest appointment for Pfizer's oncology business

    • Last Update: 2021-02-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    recently, Pfizer's Rare Diseases and Oncology Business Group 2 and Oncology Business Group 2 welcomed new appointments.Rare Diseases and Oncology GroupColleagues will report directly to Ms. Li Xueqin, Senior Sales Director of Pfizer Biopharmaceutical Group China Rare Diseases and Oncology Business Group: ms.Ms. Cai Guo, Senior Medical Letter Communication Regional Manager, RCCGI Southern Region, Location: Guangzhou. Responsible for sales management of RCCGI product lines in Shanghai, Guangdong, Guangxi, Zhejiang, Fujian, Jiangxi, Henan, Hubei, Hunan, Yunnan, Guizhou, Sichuan and Chongqing. Ms. Cai graduated with a Bachelor of Engineering degree in Biopharmaceuticals from China Pharmaceutical University. He joined Pfizer as Regional Manager in 2015 and was promoted to Regional Manager in 2018. During her time in office, Ms. Cai has accumulated extensive experience in sales management and strategy development, focusing on the creation and talent development of high-performance teams, delivering talent to different product lines, continuously leading the team to drive business innovation and continuously breaking milestones.Mr. Zhu Wei, Senior Medical Information Communication Regional Manager, Shanghai, is responsible for the sales management of the national blood product line. Mr. Zhu graduated from Zhejiang University of Technology with a master's degree in bioengineering and has 15 years of experience in the industry. In 2009 as a sales specialist to join Pfizer, has a wealth of product line sales experience and sales management experience, has MICS, DM, RM, the former Blood South Regional Manager, in the delivery results, strategic thinking, talent development, innovation and development, platform construction and other aspects of outstanding leadership, and continue to lead the team to achieve great results.The following colleagues of Group 2of the Oncology Business will report directly to Mr. Yue Jie, Sales Director of Pfizer Biopharmaceutical Group China Group II: Mr.Mr. Tian Xiaojia, Senior Medical Information Communication Regional Manager, North District 1 District, Oncology Business Group II, Beijing, Location. Mr. Tian Xiaojia graduated from Shenyang Pharmaceutical University with a clinical degree. He joined Pfizer in 2007 and has served as Medical Information Communication Specialist, Regional Manager, Regional Promotion Manager, Regional Manager, etc., where he has been responsible for sales, regional markets and training in cardiovascular, anti-infectant, tumor and other fields.Mr. Ma Jun, Manager, Medical Information Communication Area, North Second District, Oncology Business Group II, Shenyang. Responsible for sales management of breast tumor product lines in Shandong, Henan, Heilongjiang, Jilin, Liaoning and Inner Mongolia. Mr. Ma Jun graduated from Shenyang Agricultural University with a major in biotechnology and joined Pfizer as Regional Manager of Heji Oncology Team in 2017 and was promoted to Regional Manager of North 2nd District in June 2019, leading the team to achieve sustained high growth.Mr. Shi Yujun, Manager, Medical Information Communication Region, East District, Group II of Cancer Business, Shanghai. Responsible for the sales of breast tumor product line in Shanghai, Jiangsu and Anhui. Mr. Shi Yujun graduated from Zhejiang University of Commerce and Industry with a master's degree in business administration and an undergraduate degree in chemistry. He joined Pfizer as Senior Regional Manager in early February 2012 and has been responsible for the promotion of ru'xian breast cancer chemotherapy products and Aibo's new product line. In June 2019, he was promoted to manager of the East Region, leading the Su-Yuan team to achieve new breakthroughs in performance, beida and innovation.Ms. Huang Xu, Three-star Senior Medical Information Communication Area Manager, East 2nd District, Hangzhou, 2nd Group of Oncology Business. Responsible for the sales management of breast tumor product lines in Zhejiang, Jiangxi and Fujian.Mr. Cai Xiangxuan, Senior Medical Information Communication Regional Manager of The Second Group of Oncology Business, Guangzhou, is responsible for the sales management of breast tumor product lines in Guangdong, Guangxi, Hubei, Hunan and Hainan. (Sina Pharmaceutical News
    )
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.